Immunome (IMNM)
NASDAQ:IMNM
Immunome (IMNM) Ownership Overview
4.79% Insiders
30.19% Mutual Funds
32.89% Other Institutional Investors
10.86% ETFs
21.28% Public Companies and
Individual Investors
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail, and individual investors. Approximately 73.93% of the company’s stock is owned by Institutional Investors, 4.79% is owned by Insiders, and 21.28% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 23, 2026 | xxxxxxxxxxxxx | $1335626 | |
Mar 12, 2026 | xxxxxxxxxxxxx | $43670 | |
Dec 30, 2025 | xxxxxxxxxxxxx | $100018 | |
Dec 22, 2025 | xxxxxxxxxxxxx | $149053 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $189754 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $3756014 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $33839549 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $79604321 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,190,237 | Institution | 5.47% | 126,033,225 | |
| 5,179,714 | Institution | 4.58% | 105,458,977 | |
| 5,127,736 | Institution | 4.53% | 104,400,705 | |
| 4,685,441 | Institution | 4.14% | 95,395,579 | |
| 4,245,267 | Institution | 3.75% | 86,433,636 | |
| 4,165,824 | Insider | 3.68% | 84,816,177 | |
| 3,705,974 | Institution | 3.28% | 75,453,631 | |
| 3,611,458 | Institution | 3.19% | 73,529,285 | |
| 2,779,348 | Institution | 2.46% | 56,587,525 | |
| 2,674,700 | Institution | 2.36% | 54,456,892 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,190,237 | Institution | 5.47% | 126,033,225 | |
| 5,127,736 | Institution | 4.53% | 104,400,705 | |
| 4,245,267 | Institution | 3.75% | 86,433,636 | |
| 2,779,348 | Institution | 2.46% | 56,587,525 | |
| 2,674,700 | Institution | 2.36% | 54,456,892 | |
| 2,171,072 | Institution | 1.92% | 44,203,026 | |
| 2,098,664 | Institution | 1.86% | 42,728,799 | |
| 982,436 | Institution | 0.87% | 20,002,397 | |
| 976,627 | Institution | 0.86% | 19,884,126 | |
| 887,600 | Institution | 0.78% | 18,071,536 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,136,406 | Institution | 2.77% | 77,218,316 | |
| 2,222,733 | Institution | 1.96% | 45,254,844 | |
| 1,928,665 | Institution | 1.70% | 40,482,678 | |
| 1,124,291 | Institution | 0.99% | 27,680,044 | |
| 786,400 | Institution | 0.70% | 16,011,104 | |
| 504,015 | Institution | 0.45% | 10,579,275 | |
| 446,021 | Institution | 0.39% | 10,981,037 | |
| 283,144 | Institution | 0.25% | 6,971,005 | |
| 255,970 | Institution | 0.23% | 5,372,810 | |
| 247,440 | Institution | 0.22% | 5,037,878 |
FAQ
Who Owns Immunome (IMNM)?
According to the latest TipRanks data, approximately 32.89% of the company's stock is held by institutional investors, 4.79% is held by insiders, and 21.28% is held by retail investors.
What percentage of Immunome (IMNM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 32.89% of Immunome (IMNM) stock is held by institutional investors.
What percentage of Immunome (IMNM) stock is held by retail investors?
According to the latest TipRanks data, approximately 21.28% of Immunome (IMNM) stock is held by retail investors.
Who owns the most shares of Immunome (IMNM)?
Fidelity Mt. Vernon Street Trust owns the most shares of Immunome (IMNM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.